EVI1 expression is rarely detected in the chronic phase of CML, but is readily detected in a significant proportion (25–40%) of blast crisis of CML, suggesting that acquisition of EVI1 expression can drive progression into blast crisis48,49. Here, MECOM is linked to chronic myelogenous leukemia, BCR-ABL1 positive.